In focus
NORROY Bioscience Takes Radiopharmaceutical Pipeline to EANM With Eight Top-Rated Oral Presentations
NORROY Bioscience presented its radiopharmaceutical pipelines in eight Top Rated Oral Presentations and three e-posters at the EANM'26 congress in Vienna, spanning prostate cancer, renal cell carcinoma and other indications.
Read the story